Effect of sex and estrogens on neuronal activation in an animal model of migraine

Headache

Volumn 53, Issue 2, 2013, Pages 288-296

  Greco, Rosaria ^a   Tassorelli, Cristina ^a   Mangione, A Stefania ^a   Smeraldi, Antonella ^a   Allena, Marta ^a   Sandrini, Giorgio ^a   Nappi, Giuseppe ^a   Nappi, Rossella E ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

castration; estrogen; migraine; nitroglycerin; sex

Indexed keywords

E 851550; ESTRADIOL BENZOATE; GLYCERYL TRINITRATE; PLACEBO; PROTEIN FOS; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; AREA POSTREMA; ARTICLE; BRAIN; CELL ACTIVATION; CENTRAL NUCLEUS (AMYGDALA); CONTROLLED STUDY; FEMALE; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; MALE; MIGRAINE; NERVE CELL; NONHUMAN; NUCLEUS TRIGEMINALIS CAUDALIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SEX DIFFERENCE; SOLITARY TRACT NUCLEUS; SUPRAOPTIC NUCLEUS;

ANALYSIS OF VARIANCE; ANIMALS; BRAIN; CONTRACEPTIVE AGENTS; DISEASE MODELS, ANIMAL; ESTRADIOL; FEMALE; GENE EXPRESSION REGULATION; MALE; MIGRAINE DISORDERS; NITROGLYCERIN; ONCOGENE PROTEINS V-FOS; OVARIECTOMY; RATS; RATS, SPRAGUE-DAWLEY; SEX CHARACTERISTICS; VASODILATOR AGENTS;

EID: 84874409792     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2012.02249.x     Document Type: Article

References (46)

1. Di Clemente L, Coppola G, Magis D, et al,. Nitroglycerin sensitises in healthy subjects CNS structures involved in migraine pathophysiology: Evidence from a study of nociceptive blink reflexes and visual evoked potentials. Pain. 2009; 144: 156-161.
2. Oshinsky ML, Luo J,. Neurochemistry of trigeminal activation in an animal model of migraine. Headache. 2006; 46: S39-S44.
3. Scharfman HE, MacLusky NJ,. Estrogen-growth factor interactions and their contributions to neurological disorders. Headache. 2008; 48: S77-S89.
4. Brandes JL,. The influence on migraine: A systematic review. JAMA. 2006; 295: 1824-1180.
5. Bereiter DA, Cioffi JL, Bereiter DF,. Oestrogen receptor-immunoreactive neurons in the trigeminal sensory system of male and cycling female rats. Arch Oral Biol. 2005; 50: 971-979.
6. Marcus DA,. Estrogen and tension-type headache. Curr Pain Headache Rep. 2001; 5: 449-453.
7. Fillingim RB, Edwards RR,. The association of hormone replacement therapy with experimental pain responses in postmenopausal women. Pain. 2001; 92: 229-234.
8. MacGregor A,. Oestrogen replacement and migraine aura. Headache. 1999; 39: 674-678.
9. Sachs M, Pape HC, Speckmann EJ, Gorji A,. The effect of estrogen and progesterone on spreading depression in rat neocortical tissues. Neurobiol Dis. 2007; 25: 27-34.
10. Tassorelli C, Joseph SA,. Systemic nitroglycerin induces Fos immunoreactivity in brainstem and forebrain structures of the rat. Brain Res. 1995; 682: 167-178.
11. Tassorelli C, Joseph SA, Buzzi G, Nappi G,. The effect on the central nervous system of nitroglycerin-Putative mechanisms and mediators. Prog Neurobiol. 1999; 57: 606-624.
12. Tassorelli C, Greco R, Sandrini G, Nappi G,. Central components of the analgesic/antihyperalgesic effect of nimesulide: Studies in animal models of pain and hyperalgesia. Drugs. 2003a; 63: 9-22.
13. Tassorelli C, Greco R, Wang D, Morelli G, Nappi G,. Nitroglycerin induces hyperalgesia in rats: A time-course study. Eur J Pharm. 2003b; 464: 159-162.
14. Buzzi MG, Tassorelli C,. Experimental models of migraine. Handb Clin Neurol. 2010; 97: 109-123.
15. Vamos E, Fejes A, Koch J, et al,. Kynurenate derivative attenuates the nitroglycerin-induced CamKIIα and CGRP expression changes. Headache. 2010; 50: 834-843.
16. Lambert GA, Donaldson C, Boers PM, Zagami AS,. Activation of trigeminovascular neurons by glyceryl trinitrate. Brain Res. 2000; 887: 203-210.
17. Petraglia F, Peñalva A, Locatelli V, et al,. Effect of gonadectomy and gonadal steroid replacement on pituitary and plasma beta-endorphin levels in the rat. Endocrinology. 1982; 111: 1224-1229.
18. Viau V, Meaney MJ,. Variations in the hypothalamic-pituitary-adrenal response to stress during the estrous cycle in the rat. Endocrinology. 1991; 129: 2503-2511.
19. Taylor GT, Farr S, Klinga K, Weiss J,. Chronic fluoxetine suppresses circulating estrogen and the enhanced spatial learning of estrogen-treated ovariectomized rats. Psychoneuroendocrinology. 2004; 29: 1241-1249.
20. Tassorelli C, Joseph SA, Nappi G,. Neurochemical mechanisms of nitroglycerin-induced neuronal activation in rat brain: A pharmacological investigation. Neuropharmacology. 1997; 36: 1417-1424.
21. Tassorelli C, Joseph SA, Nappi G,. Reciprocal circuits involved in nitroglycerin-induced neuronal activation of autonomic regions and pain pathways: A double immunolabeling and tract-tracing study. Brain Res. 1999; 842: 294-310.
22. Hubscher CH, Brooks DL, Johnson JR,. A quantitative method for assessing stages of the rat estrous cycle. Biotech Histochem. 2005; 80: 79-87.
23. Tassorelli C, Greco R, Morazzoni P, Riva A, Sandrini G, Nappi G,. Parthenolide is the component of tanacetum parthenium that inhibits nitroglycerin-induced Fos activation: Studies in an animal model of migraine. Cephalalgia. 2005; 25: 612-621.
24. Tassorelli C, Sandrini G, Cecchini AP, Nappi RE, Sances G, Martignoni E,. Changes in nociceptive flexion reflex threshold across the menstrual cycle in healthy women. Psychosom Med. 2002; 64: 621-626.
25. Chesterton LS, Barlas P, Foster NE, Baxter GD, Wright CC,. Gender differences in pressure pain threshold in healthy humans. Pain. 2003; 101: 259-266.
26. Frot M, Feine JS, Bushnell MC,. Sex differences in pain perception and anxiety. A psychophysical study with topical capsaicin. Pain. 2004; 108: 230-236.
27. Cairns BE, Hu JW, Arendt-Nielsen L, Sessle BJ, Svensson P,. Sex-related differences in human pain perception and rat afferent discharge evoked by injection of glutamate into the masseter muscle. J Neurophysiol. 2001; 86: 782-791.
28. Nappi RE, Nappi G,. Neuroendocrine aspects of migraine in women. Gynecol Endocrinol. 2012; 28 (Suppl. 1): 37-41.
29. Nappi RE, Berga SL,. Migraine and reproductive life. Handb Clin Neurol. 2010; 97: 303-322.
30. Vogler B, Rapoport AM, Tepper SJ, Sheftell F, Bigal ME,. Role of melatonin in the pathophysiology of migraine: Implications for treatment. CNS Drugs. 2006; 20: 343-350.
31. Durham PL, Vause CV, Derosier F, McDonald S, Cady R, Martin V,. Changes in salivary prostaglandin levels during menstrual migraine with associated dysmenorrhea. Headache. 2010; 50: 844-851.
32. Reuter U, Chiarugi A, Bolay H, Moskowitz MA,. Nuclear factor-kappaB as a molecular target for migraine therapy. Ann Neurol. 2002; 51: 507-516.
33. Greco R, Tassorelli C, Cappelletti D, Sandrini G, Nappi G,. Activation of the transcription factor NF-kappaB in the nucleus trigeminalis caudalis in an animal model of migraine. Neurotoxicology. 2005; 26: 795-800.
34. Chen Z, Yuhanna IS, Galcheva-Gargova Z, Karas RH, Mendelsohn ME, Shaul PW,. Estrogen receptor alpha mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. J Clin Invest. 1999; 103: 401-406.
35. Pardutz A, Krizbai I, Multon S, Vecsei L, Schoenen J,. Systemic nitroglycerin increases nNOS levels in rat trigeminal nucleus caudalis. Neuroreport. 2000; 11: 3071-3075.
36. Reuter U, Bolay H, Jansen-Olesen I, et al,. Delayed inflammation in rat meninges: Implications for migraine pathophysiology. Brain. 2001; 124: 2490-2502.
37. Pellegrino DA, Galea E,. Estrogen and cerebrovascular physiology and patholophysiology. J Pharmacol. 2001; 86: 137-158.
38. Florian M, Lu Y, Angle M, Magder S,. Estrogen induced changes in Akt-dependent activation of endothelial nitric oxide synthase and vasodilation. Steroids. 2004; 69: 637-645.
39. Krause DN, Duckles SP, Pelligrino DA,. Influence of sex steroid hormones on cerebrovascular function. J Appl Physiol. 2006; 101: 1252-1261.
40. Ceccarelli S, Grandison L, Scott RE, Pfaff DW, Kow LM,. Estradiol regulation of nitric oxide synthase mRNAs in rat hypothalamus. Neuroendocrinology. 1996; 64: 357-363.
41. Martin VT, Lee J, Behbehani MM,. Sensitization of the trigeminal sensory system during different stages of the rat estrous cycle: Implications for menstrual migraine. Headache. 2007; 47: 552-563.
42. Bereiter DA, Barker DJ,. Hormone-induced enlargement of receptive fields in trigeminal mechanoreceptive neurons. I Time course, hormone, sex and modality specificity. Brain Res. 1980; 184: 395-410.
43. Raddant AC, Russo AF,. Calcitonin gene-related peptide in migraine: Intersection of peripheral inflammation and central modulation. Expert Rev Mol Med. 2011; 13: e36.
44. Greco R, Tassorelli C, Sandrini G, Di Bella P, Buscone S, Nappi G,. Role of calcitonin gene-related peptide and substance P in different models of pain. Cephalalgia. 2008; 28: 114-126.
45. Yang Y, Ozawa H, Lu H, et al,. Immunocytochemical analysis of sex differences in calcitonin gene-related peptidein the rat dorsal root ganglion, with special reference to estrogen and its receptor. Brain Res. 1998; 791: 35-42.
46. Pardutz A, Multon S, Malgrange B, Parducz A, Vecsei L, Schoenen J,. Effect of systemic nitroglycerin on CGRP and 5-HT afferents to rat caudal spinal trigeminal nucleus and its modulation by estrogen. Eur J Neurosci. 2002; 15: 1803-1809.